ESMOYOC

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

ESMOYOC

Dec 8, 2024, 07:04 | Blog

Matteo Lambertini: My last session as part of the ESMOYOC

Matteo Lambertini, Consultant in medical oncology at the IRCCS Policlinico San Martino Hospital, shared a…

Dec 7, 2024, 11:09 | Blog

Matteo Lambertini: First ESMOYOC session at ESMO Asia 2024

Matteo Lambertini shared a post on X: "Full house for the first ESMOYOC session at ESMO…

May 18, 2024, 10:02 | Societies

Matteo Lambertini: What a big honor to have Sara Tolaney at our ESMOYOC session

Matteo Lambertini, Medical Oncologist at San Martino, shared on X: . "What a big honor…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023